Facts
The French Athletics Federation (Fédération Française d'Athlétisme, FFA) charges respondent M21 for a violation of the Anti-Doping Rules. During an athletics event on September 24, 2006, a sample was taken for doping test purposes. The analysis of the sample showed the presence of prednisolone and prednisone which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.
History
The respondent had used pharmaceutical products and claims that one contained prednisolone and prednisone. They were mentioned on the doping control form. However one of the products contained a Beta-2 agonist which wasn't detected during the doping test. The products were used to treat a neglected cold. The panel regards this as a case of self medication which makes it an unjustifiable medical treatment.
Decision
1. The sanction is a period of ineligibility of one month in which respondent can't take part in competition or sport manifestations organized by FFA and the French Triathlon Federation (FFTri).
2. The decision starts on the date of notification.
3. The decision will be published and sent to the parties involved.
